Freund John Gordon
SEC Form 4 insider trading activity
Freund John Gordon has filed 3 SEC Form 4 filings (5 transaction rows) across 2 companies, including SIBN, COLL, with disclosures dating back to 2026. 3 of those filings fall inside the rolling window. Most recent filing: Jun 8, 2026.
On the most recent filing, Freund John Gordon is listed as Director at COLLEGIUM PHARMACEUTICAL, INC. Inside the rolling window, Freund John Gordon reported no open-market purchases and 2 open-market sales totaling $143K in COLL. The largest disclosed transaction in the window is a sale of 4,127 COLL shares on May 15, 2026, worth $143K.
Companies traded
Other insiders at SIBN
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$143K
reported sales (SEC code S)
Companies
2
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Freund John Gordon made?
Freund John Gordon has filed 3 SEC Form 4 filings (5 transaction rows) across 2 companies, including SIBN, COLL since 2026.
Which companies does Freund John Gordon trade?
Freund John Gordon has filed SEC Form 4 disclosures for 2 companies, including SIBN, COLL.
When was Freund John Gordon's most recent SEC Form 4 filing?
Freund John Gordon's most recent SEC Form 4 filing on Tracefour is dated Jun 8, 2026.
What is Freund John Gordon's total buy and sell value in the current window?
Inside the rolling retention window, Freund John Gordon bought $0 and sold $143K based on SEC Form 4 filings.
What was Freund John Gordon's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 4,127 COLL shares on 2026-05-15, worth $143K, per SEC Form 4 filings.